PMID- 23381991 OWN - NLM STAT- MEDLINE DCOM- 20130514 LR - 20211203 IS - 1098-5522 (Electronic) IS - 0019-9567 (Print) IS - 0019-9567 (Linking) VI - 81 IP - 4 DP - 2013 Apr TI - The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis. PG - 1234-44 LID - 10.1128/IAI.01189-12 [doi] AB - The contraceptive depot medroxyprogesterone acetate (DMPA), with progestin as the single active compound, possesses selective glucocorticoid activity and can alter the expression of glucocorticoid receptor-regulated genes. We therefore propose that pharmacological doses of DMPA used for endocrine therapy could have significant immune modulatory effects and impact on susceptibility to, as well as clinical manifestation and outcome of, infectious diseases. We investigated the effect of contraceptive doses of DMPA in two different murine Mycobacterium tuberculosis models. Multiplex bead array analysis revealed that DMPA altered serum cytokine levels of tumor necrosis factor alpha (TNF-alpha), granulocyte colony-stimulating factor (G-CSF), and interleukin 10 (IL-10) in C57BL/6 mice and gamma interferon (IFN-gamma) in BALB/c mice. DMPA also suppressed antigen-specific production of TNF-alpha, G-CSF, IL-10, and IL-6 and induced the production of IP-10 in C57BL/6 mice. In BALB/c mice, DMPA altered the antigen-specific secretion of IFN-gamma, IL-17, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, and monocyte chemotactic protein 1 (MCP-1). Furthermore, we show that C57BL/6 mice treated with doses of DMPA, which result in serum concentrations similar to those observed in contraceptive users, have a significantly higher bacterial load in their lungs. Our data show for the first time that DMPA impacts tuberculosis (TB) disease severity in a mouse model and that the effects of this contraceptive are not confined to infections of the genital tract. This could have major implications for the contraceptive policies not only in developing countries like South Africa but also worldwide. FAU - Kleynhans, Leanie AU - Kleynhans L AD - DST/NRF Centre of Excellence for Biomedical TB Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. FAU - Du Plessis, Nelita AU - Du Plessis N FAU - Allie, Nasiema AU - Allie N FAU - Jacobs, Muazzam AU - Jacobs M FAU - Kidd, Martin AU - Kidd M FAU - van Helden, Paul D AU - van Helden PD FAU - Walzl, Gerhard AU - Walzl G FAU - Ronacher, Katharina AU - Ronacher K LA - eng GR - U2R TW007370/TW/FIC NIH HHS/United States GR - 1U2RTW007370/3/PHS HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130204 PL - United States TA - Infect Immun JT - Infection and immunity JID - 0246127 RN - 0 (Contraceptive Agents) RN - 0 (Cytokines) RN - 0 (Immunologic Factors) RN - C2QI4IOI2G (Medroxyprogesterone Acetate) SB - IM MH - Animals MH - Contraceptive Agents/*administration & dosage/adverse effects MH - Cytokines/*blood/metabolism MH - Disease Models, Animal MH - Female MH - Immunologic Factors/*administration & dosage/adverse effects MH - *Immunosuppression Therapy MH - Medroxyprogesterone Acetate/*administration & dosage/adverse effects MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mycobacterium tuberculosis/*immunology MH - Tuberculosis/*immunology PMC - PMC3639598 EDAT- 2013/02/06 06:00 MHDA- 2013/05/15 06:00 PMCR- 2013/10/01 CRDT- 2013/02/06 06:00 PHST- 2013/02/06 06:00 [entrez] PHST- 2013/02/06 06:00 [pubmed] PHST- 2013/05/15 06:00 [medline] PHST- 2013/10/01 00:00 [pmc-release] AID - IAI.01189-12 [pii] AID - 01189-12 [pii] AID - 10.1128/IAI.01189-12 [doi] PST - ppublish SO - Infect Immun. 2013 Apr;81(4):1234-44. doi: 10.1128/IAI.01189-12. Epub 2013 Feb 4.